Stage Cell Therapeutics' Acquisition

Stage Cell Therapeutics was acquired by Juno Therapeutics on May 12, 2015.

Stage Cell Therapeutics, founded in 2005, is a privately held biotech company. Based on its proprietary Streptamer technology, Stage is aiming to become an important player in cell therapy. The unique…

Articles about Stage Cell Therapeutics' Acquisition: